within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AP10_Elbasvir;
model Elbasvir 
   extends Pharmacolibrary.Drugs.ATC.J.J05AP10;

  annotation(Documentation(
    info ="<html><body><p>Elbasvir is an oral, direct-acting antiviral drug that acts as an inhibitor of the hepatitis C virus (HCV) NS5A protein, which is essential for viral replication. It is approved for use in combination with grazoprevir in the treatment of chronic HCV infection in adults. Elbasvir is currently used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Sulejmani, N, et al., &amp; Gordon, SC (2016). Pharmacodynamics and pharmacokinetics of elbasvir and grazoprevir in the treatment of hepatitis C. <i>Expert opinion on drug metabolism &amp; toxicology</i> 12(3) 353–361. DOI:<a href=&quot;https://doi.org/10.1517/17425255.2016.1148685&quot;>10.1517/17425255.2016.1148685</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26849059/&quot;>https://pubmed.ncbi.nlm.nih.gov/26849059</a></p></li><li><p>Marshall, WL, et al., &amp; Yeh, WW (2018). Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment. <i>European journal of drug metabolism and pharmacokinetics</i> 43(3) 321–329. DOI:<a href=&quot;https://doi.org/10.1007/s13318-017-0451-9&quot;>10.1007/s13318-017-0451-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29247332/&quot;>https://pubmed.ncbi.nlm.nih.gov/29247332</a></p></li><li><p>Karaoui, LR, et al., &amp; Chahine, EB (2017). Elbasvir-grazoprevir: A new direct-acting antiviral combination for hepatitis C. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 74(19) 1533–1540. DOI:<a href=&quot;https://doi.org/10.2146/ajhp160558&quot;>10.2146/ajhp160558</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28947524/&quot;>https://pubmed.ncbi.nlm.nih.gov/28947524</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Elbasvir;
